Protara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced financial results for the full year and fourth quarter ended December 31, 2023 and provided a business update.
Publié le: 2024-03-13 12:00:00
Lorem ipsum dolor sit amet consectetur adipisicing elit. Accusamus quos id harum qui eos libero fugit distinctio, iste similique quibusdam
ONLY AVAILABLE IN PAID PLANS

Quelques suggestions